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Edited by Judit Ova´diAbstract Muscle fructose-1,6-bisphosphatase (FBPase) is
highly sensitive toward inhibition by AMP and calcium ions.
In allosteric inhibition by AMP, a loop 52–72 plays a decisive
role. This loop is a highly conservative region in muscle and liver
FBPases. It is feasible that the same region is involved in the
inhibition by calcium ions. To test this hypothesis, chemical mod-
iﬁcation, limited proteolysis and site directed mutagenesis Glu69/
Gln were employed. The chemical modiﬁcation of Lys71–72 and
the proteolytic cleavage of the loop resulted in the signiﬁcant de-
crease of the muscle FBPase sensitivity toward inhibition by cal-
cium ions. The mutation of Glu69ﬁ Gln resulted in a 500-fold
increase of muscle isozyme I0.5 vs. calcium ions. These results
demonstrate the key role that the 52–72 amino acid loop plays
in determining the sensitivity of FBPase to inhibition by AMP
and calcium ions.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Fructose-1,6-bisphosphatase (FBPase) catalyses the hydroly-
sis of fructose-1,6-bisphosphate to fructose-6-phosphate and
orthophosphate in the presence of divalent cations such as mag-
nesium, manganese or zinc [1–3]. Both muscle and liver FBPase
isozymes have been discovered in mammalian tissues. The for-
mer participates in glycogen synthesis from lactate (glyconeo-
genesis), the latter is a regulatory enzyme involved in the
gluconeogenesis. The kinetic properties of both isozymes are
virtually identical: both are inhibited competitively by fruc-
tose-2,6-bisphosphate and allosterically byAMP [4–6]. The fun-
damental diﬀerence between the liver and the muscle isozyme is
their sensitivity toward AMP inhibition. I0.5 of the muscle iso-
zyme is in the range of 0.05–1 lM, whilst the corresponding va-
lue of the liver isozyme is in the range of 5–15 lM [3,6].
Mammalian FBPases are homotetrameric enzymes [7]. The
tertiary structure of each monomer is composed of two do-
mains: the Fru-1,6-P2 domain containing the active site and
the AMP binding domain with the AMP binding site. The me-
tal binding site is located between the Fru-1,6-P2 and AMP
binding domains [8,9]. The mammalian liver FBPase exists at
least in two quaternary conformations called R and T depend-*Corresponding author. Fax: +48 71 3759213.
E-mail address: dzugajan@biol.uni.wroc.pl (A. Dzugaj).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.02.051ing on the relative concentrations of the enzyme eﬀectors
[8,10]. The mammalian liver FBPase consists of the upper di-
mer (C1 and C2) and the lower dimer (C3 and C4). It has been
shown that the communication between the subunits within
the dimers is possible by interaction of 7–15 N–terminal resi-
dues and the loop 187–196 of C1 with the loop 52–72 of C2.
A proposed mechanism for the allosteric regulation of catalysis
involves three conformational states of the loop 52–72 called:
engaged, disengaged and disordered. FBPase is active when
the loop 52–72 oscillates between the engaged and disordered
state, and inactive or less active when the loop 52–72 is stabi-
lized in its disengaged conformation [11]. Although the crystal-
lographic study of muscle FBPase has been reported, no
details concerning the conformation of this isozyme have been
released [12]. Nevertheless, it seems reasonable to assume that
the mammalian muscle isozyme also exists in conformations R
and T and the similar mechanism for allosteric regulation in-
cludes three conformational states of the loop 52–72: engaged,
disengaged, and disordered.
Recently,wehave reported [13] that themuscleFBPase, unlike
the liver isozyme, is strongly inhibited by calcium ions. The
determined I0.5 was ca. 0.6 lM.Wehave also found that calcium
causes the dissociation of FBPase aldolase complex, which is
necessary for glyconeogenesis to proceed and the dissociation
of FBPase from the Z-line [14]. On the basis of our results we
have postulated that calcium ions regulate glyconeogenesis.
Searching for the origin of the high sensitivity of muscle
FBPase toward calcium ions the chemical modiﬁcation with
ﬂuorescein and tetramethyl-rhodamine isothiocyanate (FITC
and TRITC), proteolytic modiﬁcation with subtilisin, and
site-directed mutagenesis was employed.
The results of our investigation lead us to conclusion that
the loop 52–72 is critical for the inhibition of the muscle
FBPase by calcium and that the Glu69 is essential for the high
aﬃnity of the enzyme toward calcium ions.2. Materials and methods
2.1. Enzyme puriﬁcation and activity determination
FBPase was isolated from the rabbit muscle according to the method
previously described [6]. The FBPase concentration was determined
spectrophotometrically at k = 280 nm, assuming that A1%1 cm ¼ 6:3.
The puriﬁed enzyme was checked for its homogeneity on SDS–PAGE,
as previously described [15].
2.2. Kinetic studies
Kinetic experiments were performed at pH 7.5 and 37 C as previ-
ously described [16]. One milliliter of the assay mixture contained:blished by Elsevier B.V. All rights reserved.
Table 1
The region 50–80 of mammalian muscle and liver FBPases
Source Muscle isozyme Liver isozyme
Man kaglahlygi agsvnvtgde vkkldvlsnsl kagiahlygi agstnvtgdq vkkldvlsndl
Rat kaglanlygi agsvnvtgde vkkldvlsnsl qagiaqlyg iagstnvtgdq vkkldilsndl
Mouse kaglanlygi sgsvnvtgde vkkldvlsnsl kagiahlygi agstnvtgdq vkkldvlsndl
Rabbit kaglahlygi agtvnvtgde vkkldvlsnal kagiahlygi agstnvtgdq vkkldvlsndl
The loop 52–72 is underlined.
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Fig. 1. The eﬀect of calcium ions on the activity of the native rabbit
muscle FBPase (N-FBPase) and the enzyme modiﬁed with ﬂuorescein
isothiocyanate (FITC-FBPase), tetramethyl-rhodamine isothiocyanate
(TRITC-FBPase) and digested with subtilisin (S-FBPase). Each
modiﬁcation decreases the enzymes sensitivity to calcium ions.
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NADP, 20 units glucose-6-phosphate dehydrogenase, 10 units glu-
cose-6-phosphate isomerase and various concentrations of Fru-1,6-
P2. The substrate was used to start the reaction. One unit of enzyme
activity is deﬁned as the amount of the enzyme that catalyses the
formation of 1 lmol of product per minute. Spectrophotometric mea-
surements were performed with a HP 8452A diode array spectropho-
tometer. The determination of I0.5 and Hill coeﬃcient for: AMP and
Ca+2 as well as A0.5 and Hill coeﬃcient for Mg
2+ were performed using
the GraFit 3 programme [17]. All other kinetic parameters such as: Km,
Ki for Fru-2,6-P2 and Kis for Fru-1,6-P2 (with its standard error) were
calculated with Excel and GraFit assuming the uncompetitive inhibi-
tion of the enzyme by the substrate [6]. The AMP concentration was
determined spectrophotometrically using 15400 M1/cm1 as the
molar absorption coeﬃcient at 260 nm. To measure Fru-2,6-P2 con-
centration, this compound was hydrolyzed with HCl at pH 2.0 for
10 min and fructose 6-phosphate was determined as previously
described [16].
2.3. Fluorescent labeling
Fluorescently labeled FBPases were obtained by the modiﬁcation of
the proteins with FITC and TRITC [18]. The lack of the proteolysis of
ﬂuorescently labeled proteins was checked by 10% SDS–PAGE [15].
The number of the ﬂuorochrome molecules conjugated to the enzymes
was determined spectrophotometrically. During the labeling (5 h) the
sample was incubated at 4 C and dialyzed extensively against PBS
pH 7.4.
2.4. Subtilisin cleavage
The sample of FBPase was incubated for 3 h at 37 C with the sub-
tilisin in the molar ratio 100:1 in the BTP/HCl buﬀer pH 7.5, contain-
ing MgCl2, EDTA and KCl, as described for kinetic studies.
2.5. Site-directed mutagenesis
Themutagenesis of the muscle and liver FBPase was performed using
theAltered SitesII in vitroMutagenesis System (Promega) according to
the protocol provided. First, an EcoRI–PstI fragments encoding the N-
terminal 190 bp sequence of muscle FBPase gene and the complete
1070 bp sequence of liver FBPase gene were obtained by the digestion
of pHMF2 and pJT2 plasmids [19]. Then these two genes were cloned
into the pALTER vector supplied by the manufacturer. Next, to gener-
ate the Glu69ﬁ Gln mutation in the muscle FBPase and the
Gln69ﬁ Glu mutation in the liver FBPase, the resulting pED4 (muscle
FBPase) and pED2 (liver FBPase) plasmids were mutagenized with
primers MEQ69: 5 0-phospho-CGTGACGGGAGATCAGGTGA-
AGAAACTG-3 0 and LQE69: 5 0-phospho-CCAACGTGACAGGT-
GATGAGGTTAAGAAGCTGGACC-3 0 (mutations underlined),
respectively. Finally, the mutations were conﬁrmed by sequencing and
the mutated EcoRI–PstI fragments of muscle and liver FBPase were re-
cloned into the pHMF2 and pJT2 expression plasmids based on
pKK223-3 (Pharmacia Biotech) to form pEQ69 (muscle Glu69ﬁ Gln
FBPase) and pQE69 (liver Gln69ﬁ Glu FBPase) plasmids.
2.6. Expression and puriﬁcation of wild-type and mutant FBPases
The puriﬁcation protocol was similar to the former, describing the
isolation of FBPase from the rabbit muscle. The 2.5 L bacterial culture
was collected by the centrifugation. The remaining pellet was sus-
pended in BugBuster (Prospecta) solution 1 g: 5 ml for homogeniza-
tion, left in the room temperature for 20 min and centrifuged. The
succeeding steps were taken as described for the puriﬁcation of the rab-
bit muscle FBPase. The supernatant was collected and fractionated
with ammonium sulfate, and the aﬃnity chromatography on phos-
pho-cellulose was employed as described.3. Results and discussion
It has been previously reported that calcium is rather a weak
inhibitor of the muscle FBPase [20]. We have found recently
that calcium is the strong inhibitor of the muscle FBPase
and that proteolysis decreases the sensitivity of the enzyme to-
ward calcium [13]. Perhaps the reported low aﬃnity of the
muscle FBPase to calcium ions was due to a partial proteolysis
of the enzyme.
The mechanism of the muscle FBPase inhibition by calcium
is unknown. The interaction of calcium with FBPase may in-
duce conformational changes of the enzyme stabilizing the
loop 52–72 in the disengaged position thus resulting in an inac-
tive or less active isozyme form. To test this hypothesis we em-
ployed the chemical modiﬁcation of FBPase with FITC and
TRITC in order to introduce ﬂuorescein or tetramethyl-rhoda-
mine to e-amino group of the exposed lysines. The determined
stoichiometry of the modiﬁcation with FITC was 1.8 ﬂuores-
cein molecule per tetramer of FBPase and with the use of
TRITC it was 2.8 tetramethyl-rhodamine molecule per FBPase
tetramer. To determine the site of ﬂuorescent labels binding
the mass spectrometry was employed. The labeled protein
was electrophorized on SDS 10% polyacrylamide gels and pro-
tein bands were investigated with ESI MS (electrospray ioniza-
tion mass spectrometry). The identiﬁed tryptic peptides
marked with ﬂuorescent labels belonged to the regions:
K71–72, K141, K204–205 and C-terminal peptide.
In Table 1 the region 49–78 (containing Lys71–72) of muscle
and liver FBPases is presented. The relatively large group
(400–500 Da) of ﬂuorescein or tatramethyl-rhodamine bound
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Fig. 2. The eﬀect of calcium ions on the recombinant and mutant
muscle and liver FBPases. The mutation of muscle FBPase
Glu69ﬁ Gln resulted in more than 500-fold increase of I0.5 regarding
the inhibition by calcium ions.
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Fig. 3. The activation of the recombinant wild type and mutated
FBPases by magnesium ions. Both wild type enzymes have similar
sensitivity to magnesium (0.15–0.19 mM) however the mutants have
either increased (liver type Gln/Glu69) or decreased (muscle type Glu/
Gln69) sensitivity to magnesium ions.
M. Zarzycki et al. / FEBS Letters 581 (2007) 1347–1350 1349to the loop could result in a steric hindrance precluding oscil-
lation of the loop and therefore decreasing the FBPase sensi-
tivity toward the inhibition with calcium ions.
The subtilisin cleaves three peptide bonds in the region of
57–67 of the liver FBPase, nevertheless the N-terminal peptide
remained associated with the main protein and the enzyme was
still active [21,22]. A similar eﬀect of subtilisin has been also
observed in the muscle FBPase [22]. The eﬀect of calcium ions
on the activity of the native and modiﬁed muscle FBPase is
presented in Fig. 1. The sigmoidal curve of inhibition of the
native FBPase by calcium ions indicates the cooperativity in
calcium-enzyme binding. Muscle FBPase modiﬁed with FITC
or TRITC was still active although in both cases speciﬁc activ-
ities were considerably decreased.Table 2
The kinetic properties of the native rabbit muscle FBPase (N-FBPase) and
tetramethyl-rhodamine isothiocyanate (TRITC-FBPase) and digested by sub
human muscle and liver FBPases: wild type (muscle: M-FBPase-WT, liver:
M-FBPase-EQ, liver: L-FBPase-QE)
Speciﬁc activity (U/mg) Km F1,6P2 (lM) Ki F2,6P2 (l
N-FBPase 35 2.1 0.23
S.E.M. 5 S.E.M. 0.2 S.E.M. 0.03
FITC-FBPase 6 2.5 0.19
S.E.M. 3 S.E.M. 0.3 S.E.M. 0.02
TRITC-FBPase 2.5 2.0 0.13
S.E.M. 0.5 S.E.M. 0.2 S.E.M. 0.02
S-FBPase 12 2.9 0.20
S.E.M. 1 S.E.M. 0.1 S.E.M. 0.02
MFBPase-WT 27 2.6 0.20
S.E.M. 4 S.E.M. 0.2 S.E.M. 0.03
MFBPase-EQ 26 3.1 0.35
S.E.M. 5 S.E.M. 0.3 S.E.M. 0.04
LFBPase-WT 28 2.7 0.25
S.E.M. 4 S.E.M. 0.2 S.E.M. 0.02
LFBPase-QE 25 2.9 0.85
S.E.M. 3 S.E.M. 0.3 S.E.M. 0.09
Values were estimated by least square non-linear plot of:
v = {Vmax * [1 + B * (S/Ksi)]}/[1 + (Ks/S) + (Ks/Ksi) + (S/Ksi)] for Km and Ki f
and AMP [6]; n-Hill coeﬃcient. Hill coeﬃcient and S.E.M. is not provi
I0.5 > 1000 lM (S- and TRITC-FBPase, and EQ-muscle mutant). All value
mination.Comparing the region 49–78 of muscle and liver FBPases
(Table 1) we noticed that in all known liver isozymes position
69 is occupied by Gln, but in muscle isozymes Gln is substi-
tuted with Glu. It prompted us to perform site directed muta-
genesis of muscle Glu69/Gln and liver Gln69/Glu isozymes.
The eﬀect of calcium ions on the wild type and mutants of
the muscle and liver FBPase isoform are presented in Fig. 2.
Like the native enzyme isolated from the muscle tissue, the re-
combinant muscle FBPase was highly sensitive toward the
inhibition by calcium and displayed the sigmoidal curve of
inhibition. Mutations also aﬀected the aﬃnity of muscle and
the liver FBPase toward magnesium ions (Fig. 3). Mutations
only slightly aﬀected the cooperativity of the recombinant
muscle and liver FBPases.the enzyme modiﬁed with ﬂuorescein isothiocyanate (FITC-FBPase),
tilisin (S-FBPase) as well as the kinetic properties of the recombinant
L-FBPase-WT) and site-directed mutants in the position 69 (muscle:
M) I0.5 AMP (lM) I0.5 Ca
+2 (lM) n Ka Mg+2 (lM) n
0.16 0.74 1.6 162 2.1
S.E.M. 0.05 S.E.M. 0.05 S.E.M. 51
0.69 247 0.2 291 1.6
S.E.M. 0.05 S.E.M. 107 S.E.M. 82
2.00 >1000 – 350 1.4
S.E.M. 0.30 S.E.M. 74
0.95 >1000 – 213 1.7
S.E.M. 0.11 S.E.M. 65
0.15 2.00 1.7 154 2.2
S.E.M. 0.02 S.E.M. 0.3 S.E.M. 33
0.21 >1000 – 484 2.0
S.E.M. 0.02 S.E.M. 45
9.00 830 2.0 188 1.8
S.E.M. 1.1 S.E.M. 150 S.E.M. 27
38.0 360 3.1 83 1.6
S.E.M. 6.2 S.E.M. 25 S.E.M. 9
or F2,6P2 and Hill formula for Ka of magnesium, and I0.5 for calcium
ded when enzymes are practically insensitive to calcium and have
s represent the mean and standard error (S.E.M.) of triplicate deter-
1350 M. Zarzycki et al. / FEBS Letters 581 (2007) 1347–1350The determined kinetic properties of the native, the chemi-
cally modiﬁed and the digested with subtilisin muscle FBPases
as well as the recombinant human muscle and liver FBPases
have been collected in Table 2.
Km for Fr-1,6-P2 of muscle and liver isozyme were virtually
the same and neither chemical modiﬁcation nor proteolysis nor
mutations have changed this parameter. Ki for Fru-2,6-P2 of
the muscle isozyme was also unchanged by chemical modiﬁca-
tion, limited proteolysis or site directed mutagenesis. The
mutation of the liver FBPase only slightly aﬀected this param-
eter. Chemical modiﬁcation with FITC and TRITC, limited
proteolysis and site directed mutagenesis (Glu69/Gln) resulted
in the dramatic decrease of the aﬃnity of the muscle FBPase
toward calcium ions and the slight decrease of the enzyme
aﬃnity toward magnesium ions. On the contrary, the mutation
of the liver FBPase (Gln69/Glu) resulted in the increase of the
enzyme aﬃnity either to calcium or magnesium ions.
The crystallographic analysis and site-directed mutagenesis
[9,23,24] revealed three metal binding sites of the liver FBPase.
The ﬁrst site consisted of Glu97, Asp118, Asp121 and Glu280.
The second one consisted of: Glu97, Leu112, Asp118, and the
third one of: Asp68 and Glu97. The same amino acid residues
are present in the muscle isozyme with one exception: Leu112
in the liver FBPase is replaced with Lys112 in the muscle iso-
zyme. It has been reported [10] that magnesium binds to the
ﬁrst and the second metal binding site and that potassium
binds to the third site only. The ionic radius of potassium is
nearly two times larger than the corresponding radius of mag-
nesium. The ionic radius of calcium is nearly 40% larger than
magnesium. Hypothetically calcium should bind to site three
rather than to site one or two. In the muscle enzyme the pres-
ence of two acidic residues (Asp68 and Glu69) interacting with
calcium might stabilize the loop 52–72 in the disengaged con-
formation.
The crystalographic analysis and the site-directed mutagen-
esis are necessary to determine the muscle FBPase binding site
of calcium.
Hypothetically, the single point mutation (Gln69/Glu) was
the crucial step in FBPase evolution enabling the regulation
of glyconeogenesis in muscle cells by calcium ions.
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